Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome

Documenti analoghi

• FAS Haploinsufficiency Is a Common Disease Mechanism in the Human Autoimmune Lymphoproliferative Syndrome
  di: Kuehn, Hye Sun, et al.
  Pubblicazione: (2011)
• Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome
  di: Dowdell, Kennichi C., et al.
  Pubblicazione: (2010)
• Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations
  di: Price, Susan, et al.
  Pubblicazione: (2014)
• In utero and early postnatal presentation of autoimmune lymphoproliferative syndrome in a family with a novel FAS mutation
  di: Hansford, Jordan R., et al.
  Pubblicazione: (2013)
• Use of Rituximab for Refractory Cytopenias Associated with Autoimmune Lymphoproliferative Syndrome (ALPS)
  di: Rao, V. Koneti, et al.
  Pubblicazione: (2009)